Living Cell Technologies Limited

Press Releases

2017-December-21	NTCELL® and Parkinson's Clinical Trial Update (in PDF)
2017-November-15	Chairman's Address to the 2017 Annual General Meeting (in PDF)
2017-November-10	Top-line Results of LCT Parkinson's Trial Require Further Analysis (in PDF)
2017-November-9	NTCELL Clinical Study Results to be Announced on Friday 10 November (in PDF)
2017-November-7	LCT Files Pericyte Protective Agent Provisional Patent (in PDF)
2017-October-18	Appendix 4C Quarterly Cash Flow Report 30 September 2017 (in PDF)
2017-August-23	Preliminary Final Report for the Year Ended 30 June 2017 (in PDF)
2017-July-20	Appendix 4C Quarterly Cash Flow Report 30 June 2017 (in PDF)
2017-June-6	NTCELL® Continues to Halt Progression of Parkinson's Disease (in PDF)
2017-May-16	LCT Collaborates with Auckland University Centre for Brain Research to Extend Product Pipeline (in PDF)
2017-May-1	Treatment Completed for All Patients in Parkinson's Trial (in PDF)
2017-April-26	Appendix 4C Quarterly Cash Flow Report 31 March 2017 (in PDF)
2017-February-22	LCT Half Yearly Report Period Ended 31 December 2016 (in PDF)
2017-February-8	Approval Granted for Group 3 in Parkinson's Trial (in PDF)
2017-January-20	Appendix 4C Quarterly Cash Flow Report 30 December 2016 (in PDF)
2017-January-11	US Choroid Plexus Cells Patent Application Published (in PDF)
2023	2023 Press Releases
2022	2022 Press Releases
2021	2021 Press Releases
2020	2020 Press Releases
2019	2019 Press Releases
2018	2018 Press Releases
2016	2016 Press Releases
2015	2015 Press Releases
2014	2014 Press Releases
2013	2013 Press Releases
2012	2012 Press Releases
2011	2011 Press Releases
2010	2010 Press Releases
2009	2009 Press Releases
2008	2008 Press Releases
2007	2007 Press Releases